Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-28

Clinical Trial Update: Targeting Cognition in Bipolar Disorder With Pramipexole [Phase 4]

View source ↗

Summary

A Phase 4 trial update investigating pramipexole for cognition in bipolar disorder has been completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pramipexole (pramipexole)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED | Results posted: 2020-02-28